Recently, the Australian patent application "Methods and compositions for editing RNAs" – a global counterpart patent application co‑filed and owned by Peking University and EdiGene (Beijing) Biotechnology Co., Ltd., with the theme "Methods and compositions for editing RNAs" – has been granted. Previously, one patent in this same family had been granted in China, Japan, and Hong Kong SAR, China, respectively.

Beijing Caihe Law Firm was entrusted by EdiGene (Beijing) Biotechnology Co., Ltd. to provide full‑cycle consulting services for this counterpart patent application.